INDiGO

THE FASTEST PATH TO THE CLINIC

For decades, the biotechnology industry has struggled to align complex functions towards a singular goal of getting to the clinic. The process is long, expensive, resource straining, and bursting with risk.

We believe the road to the clinic is difficult enough without the inefficiencies of traditional drug development, so we are offering a better solution. With our acquisition of Aptuit in 2017, Evotec is now the only organisation with the capability to successfully deliver fully-integrated drug discovery and development programmes.

We offer a two-tiered approach to the clinic

INDiGO-Select

For a single or short list of candidates, this integrated package will fully de-risk your molecule before investing millions and months in clinical-enabling studies. In addition, this package will enhance the quality, speed of delivery, and probability of success for your clinical candidate.

INDiGO

Once your clinical candidate is selected, this fully-integrated clinical-enabling package focuses intensely on 

interdisciplinary coordination of all aspects of drug development, conducted and managed by a single Evotec team, and at a single Evotec site.

In bringing your candidate through IND filing “under one roof“, we will eliminate the inherent inefficiency of the traditional multiple-vendor approach by consolidating development to a single, cross-functional team with decades of drug development experience. All while increasing the probability and speed of success of your programme.

INDiGO key features

•   Accelerated drug development through interdisciplinary integration and expert coordination of all drug development activities “under one roof”
• Industry-leading timelines from candidate nomination to regulatory submission

• Management by experienced, dedicated project managers and drug development professionals 
• Seamless knowledge transfer across disciplines, maximising quality of overall development package 
• Custom-designed, flexible development plans allow for real-time adjustments and maximum efficiency 
• Superior project governance, perfomance review and issue escalation management

INDiGO attributes

• Integrated science “under one roof”
• Reduced tech transfer time and cost
• Flexibility and efficiency

• Aggressive timelines with track record of delivery
  • Drug development experts with pharma background
  • True extension of Partner’s organisation
  • Leads to higher quality scientific solution 
• Professional alliance and project managers 
• Top GxP standards for quality

INDiGO highlights

• More than 40 different functions across multiple disciplines
• Managed on an operational level by more than 100 experienced drug development professionals
• Industry leading timelines and excellent track record of on-time delivery
• > 35 completed programmes in the last 5 years
• High rate of client retention after first successful INDiGO programme

Evotec INDiGO: Partnering with the experts – reliably designed drug development project plans with accelerated timelines.

Find out how Evotec INDiGO integrated approach can reduce risk, accelerate development schedules and boost the efficiency of your drug development programme.

You are invited to follow our INDiGO page on LinkedIn!

FAST-TRACKED DRUG DEVELOPMENT IN JUST 37 WEEKS

A rapid and robust IND-enabling package

Learn how Evotec’s INDiGO solution allowed a small US biotech to rapidly and efficiently achieve regulatory submission of their key asset in just 37 weeks. Have a look here.